These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 16762115)

  • 61. Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.
    Kerketta AS; Babu BV
    Asia Pac J Public Health; 2009 Jan; 21(1):112-7. PubMed ID: 19124342
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mass DEC campaign for filariasis in a hyper endemic district of West Bengal.
    Haldar A; Mundle M; Haldar S; Biswas AK; Mitra SP; Mahapatra BS
    J Commun Dis; 2001 Sep; 33(3):192-7. PubMed ID: 12206039
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lymphatic filariasis in kenya since 1910, and the prospects for its elimination: a review.
    Wamae CN; Mwandawiro C; Wambayi E; Njenga S; Kiliku F
    East Afr Med J; 2001 Nov; 78(11):595-603. PubMed ID: 12219966
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.
    Lemoine JF; Desormeaux AM; Monestime F; Fayette CR; Desir L; Direny AN; Carciunoiu S; Miller L; Knipes A; Lammie P; Smith P; Stockton M; Trofimovich L; Bhandari K; Reithinger R; Crowley K; Ottesen E; Baker M
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0004954. PubMed ID: 27706162
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.
    Biritwum NK; Garshong B; Alomatu B; de Souza DK; Gyapong M; Kyelem D
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005619. PubMed ID: 28493966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Factors determining non-compliance to mass drug administration for lymphatic filariasis elimination in endemic districts of Nepal.
    Adhikari RK; Sherchand JB; Mishra SR; Ranabhat K; Devkota P; Mishra D; Ghimire YC; Gelal K; Mishra R; Paudel R; Wagle RR
    J Nepal Health Res Counc; 2014; 12(27):124-9. PubMed ID: 25726571
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India.
    Kerketta AS; Babu BV; Swain BK
    Acta Trop; 2007 Jun; 102(3):159-64. PubMed ID: 17553441
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India.
    Rath K; Nath N; Shaloumy M; Swain BK; Suchismita M; Babu BV
    Trop Biomed; 2006 Dec; 23(2):156-62. PubMed ID: 17322817
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
    Njomo DW; Kimani BW; Kibe LW; Okoyo C; Omondi WP; Sultani HM
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0009012. PubMed ID: 33370300
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of community empowerment in the elimination of lymphatic filariasis in south India.
    Rajendran R; Sunish IP; Munirathinam A; Ashok Kumar V; Tyagi BK
    Trop Biomed; 2010 Apr; 27(1):68-78. PubMed ID: 20562816
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.
    Ahorlu CSK; Koka E; Adu-Amankwah S; Otchere J; de Souza DK
    BMC Public Health; 2018 Feb; 18(1):238. PubMed ID: 29433461
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India.
    Karmakar PR; Mitra K; Chatterjee A; Jana PK; Bhattacharya S; Lahiri SK
    J Vector Borne Dis; 2011 Jun; 48(2):101-4. PubMed ID: 21715733
    [No Abstract]   [Full Text] [Related]  

  • 73. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
    [No Abstract]   [Full Text] [Related]  

  • 74. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
    Ramzy RM; El Setouhy M; Helmy H; Ahmed ES; Abd Elaziz KM; Farid HA; Shannon WD; Weil GJ
    Lancet; 2006 Mar; 367(9515):992-9. PubMed ID: 16564361
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Community's knowledge and perceptions about filarial elephantiasis and hydrocele in coastal Orissa, India.
    Rath K; Nayak AN; Babu BV
    Asia Pac J Public Health; 2007; 19(1):28-33. PubMed ID: 17784656
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana.
    Biritwum NK; Yikpotey P; Marfo BK; Odoom S; Mensah EO; Asiedu O; Alomatu B; Hervie ET; Yeboah A; Ade S; Hinderaker SG; Reid A; Takarinda KC; Koudou B; Koroma JB
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):690-695. PubMed ID: 28938053
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lymphatic filariasis: patients and the global elimination programme.
    Mackenzie CD; Lazarus WM; Mwakitalu ME; Mwingira U; Malecela MN
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S41-51. PubMed ID: 19843397
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Knowledge on lymphatic filariasis and the response to July 2002 mass treatment campaign in two communities in the Galle district.
    Yahathugoda TC; Wickramasinghe D; Liyanage TS; Weerasooriya MV; Mudalige MP; Waidyaratna EI; Samarawickrema WA
    Ceylon Med J; 2003 Sep; 48(3):74-7. PubMed ID: 14735801
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Participation in three consecutive mass drug administrations in Leogane, Haiti.
    Mathieu E; Direny AN; de Rochars MB; Streit TG; Addiss DG; Lammie PJ
    Trop Med Int Health; 2006 Jun; 11(6):862-8. PubMed ID: 16772008
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis.
    Lammie P; Milner T; Houston R
    Bull World Health Organ; 2007 Jul; 85(7):545-9. PubMed ID: 17768503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.